sellWeak
Amoroso Michael sold $25k of DTIL
President and CEO at PRECISION BIOSCIENCES INC. 3,012 shares at an average of $8.19, traded Nov 4, 2024, filed Nov 5, 2024.
Warning score
10Value
$25k
3,012 shares
Holdings after
28,537
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-121726, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 2, 2024 | MOption exercise Common Stock | +9,443 | - | - | 31,549 | Nov 5, 2024 |
| Nov 4, 2024 | SOpen-market sale Common Stock | -3,012 | $8.19 | $25k | 28,537 | Nov 5, 2024 |
| Nov 2, 2024 | MOption exercise Restricted Stock Unitsderivative | -9,443 | $0.00 | $0 | 9,444 | Nov 5, 2024 |
Related signals
Other insiders at PRECISION BIOSCIENCES INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 33Weak | buy 2 | DTIL PRECISION BIOSCIENCES INC | Buehler Kevin director | $21k | 4,320 | |
| 33Weak | buy 2 | DTIL PRECISION BIOSCIENCES INC | Brown Melinda director | $14k | 3,016 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.